Oxford Drug Design
PrivateLast Round
Crowdfunding
Mar 4, 2026
Est. Valuation
$15.17M
Total Funding Raised
$8.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oxford Drug Design is a biotechnology company that discovers and develops novel therapeutics for cancer and other diseases using a proprietary AI and machine learning platform with a core expertise in aminoacyl-tRNA synthetase (aaRS) enzymes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Drug Design Comparables
Compare Oxford Drug Design with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 79% | |
| Charm Therapeutics | 78% | |
| Optibrium | 76% | |
Oxford Drug Design Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 4, 2026 | ||||
| Grant | Feb 20, 2025 | ||||
| Grant | Sep 26, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Debt | May 19, 2022 | ||||
VC Round | Nov 5, 2019 |
Oxford Drug Design Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | Debt, VC Round |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| IP Group | VC Round |
| o2h ventures | Debt, VC Round |
| DHSC | VC Round, Grant |
| Meltwind Advisory | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 423% MoM, from 298 to 1.6K.
- Apr 16, 2026
Monthly visitors increased 5825% MoM, from 24 to 1.4K.
Oxford Drug Design Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Drug Design's valuation, stock price, and market status.